Paloma Partners’s Cartesian Therapeutics RNAC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,153	Closed	-$166K	–	2042
2019 Q3	$166K	Sell	3,153 -1,977	-39%	-$104K	﹤0.01%	1458
2019 Q2	$275K	Buy	+5,130	New	+$275K	﹤0.01%	1108